Profound Medical (PROF) Liabilities and Shareholders Equity (2018 - 2026)
Profound Medical (PROF) posted quarterly Liabilities and Shareholders Equity of $73.5 million for Q1 2026, up 20.69% year-over-year from $60.9 million in Q1 2025, and down 5.19% quarter-over-quarter from $77.5 million in Q4 2025.
Profound Medical (PROF) Liabilities and Shareholders Equity (2018 - 2026) Analysis & Trends
Profound Medical's Liabilities and Shareholders Equity history runs 9 years deep, the most recent figure standing at $73.5 million for Q1 2026.
- In Q1 2026, Liabilities and Shareholders Equity rose 20.69% year-over-year to $73.5 million; the TTM figure through Mar 2026 stood at $242.9 million (up 85.28% YoY), while the FY2025 annual figure was $77.5 million, up 10.31% from the prior year.
- Liabilities and Shareholders Equity for Q1 2026 stood at $73.5 million, down from $77.5 million in the prior quarter.
- The five-year high for Liabilities and Shareholders Equity was $77.5 million in Q4 2025, with the low at $42.3 million in Q3 2025.
- The 5-year median for Liabilities and Shareholders Equity is $62.6 million (2022), against an average of $60.3 million.
- The sharpest annual moves came in 2023 and 2024: Liabilities and Shareholders Equity tumbled 31.77% in 2023, then surged 59.78% in 2024.
- Profound Medical's Liabilities and Shareholders Equity stood at $64.4 million in 2022, then sank by 31.77% to $44.0 million in 2023, then soared by 59.78% to $70.2 million in 2024, then advanced by 10.31% to $77.5 million in 2025, then declined by 5.19% to $73.5 million in 2026.
- Business Quant data shows PROF's Liabilities and Shareholders Equity at $73.5 million in Q1 2026, $77.5 million in Q4 2025, and $42.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | 109.22 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 47.93 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 93.03 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 45.22 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 13.87 Bn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 6.46 Bn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 37.25 Bn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 31.04 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 10.74 Bn |
| 10 | Profound Medical | 247.18 Mn | 208.91 Mn | 1.95 Mn | 62.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 62.39 Mn |
| Mar 31, 2026 | 73.46 Mn |
| Dec 31, 2025 | 77.48 Mn |
| Sep 30, 2025 | 42.31 Mn |
| Jun 30, 2025 | 49.67 Mn |
| Mar 31, 2025 | 60.86 Mn |
| Dec 31, 2024 | 70.23 Mn |
| Dec 31, 2023 | 43.96 Mn |
| Dec 31, 2022 | 64.42 Mn |
| Dec 31, 2021 | 86.78 Mn |
| Dec 31, 2020 | 104.60 Mn |
| Dec 31, 2019 | 29.58 Mn |
| Jan 1, 2019 | 34.12 Mn |
| Dec 31, 2018 | 35.27 Mn |